PCN4- ECONOMIC CONSEQUENCES OF DIFFERENCES IN THE ADVERSE-EVENTS (AE) PROFILE OF CAPECITABINE vs. MAYO CLINIC (M) -REGIMEN IN PREVIOUSLY UNTREATED ADVANCED/ METASTATIC COLORECTAL CANCER.
Sep 1, 2000, 00:00
10.1016/S1098-3015(11)70759-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)70759-8/fulltext
Title :
PCN4- ECONOMIC CONSEQUENCES OF DIFFERENCES IN THE ADVERSE-EVENTS (AE) PROFILE OF CAPECITABINE vs. MAYO CLINIC (M) -REGIMEN IN PREVIOUSLY UNTREATED ADVANCED/ METASTATIC COLORECTAL CANCER.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70759-8&doi=10.1016/S1098-3015(11)70759-8
First page :
Section Title :
Open access? :
No
Section Order :
142